ALLMedicine™ Cannabis Center

Mar 18th, 2023 - The preconception period represents transgenerational opportunities to optimize modifiable risk factors associated with both short and long-term adverse health outcomes for women, men, and children. As such, preconception care is recommended to co...

Mar 18th, 2023 - Cannabis Equity Initiatives: Progress, Problems, and Potentials.|2023|Tony Yang Y,Berg CJ,Burris S,|

Mar 18th, 2023 - Cannabis is marketed as a treatment for pain. There is limited data on the prevalence of cannabis use and its correlates among Veterans prescribed opioids. To examine the prevalence and correlates of cannabis use among Veterans prescribed opioids....

Mar 18th, 2023 - In the United States, recreational and medicinal cannabis use has continually increased in recent years, including in patients undergoing bariatric surgery. However, the effects of cannabis use on morbidity and mortality after bariatric surgery ar...

Mar 17th, 2023 - While adolescent suicidal behaviour (ideation, planning, and attempt) remains a global public health concern, available county-specific evidence on the phenomenon from African countries is relatively less than enough. The present study was conduct...

Feb 8th, 2023 - Sleep complaints and cannabis use are common among University students and are related to detrimental effects on health. The aim of this study was to explore their association. This cross-sectional study based on the i-Share e-cohort included Fren...

Feb 5th, 2023 - The associations between blood pressure and cannabis use remain inconsistent. The purpose of our study was to examine gender stratified associations of cannabis use and blood pressure [systolic, diastolic blood pressure (BP), pulse pressure (PP)] ...

Jan 13th, 2023 - Background and Objective: An increasing number of countries are deciding to regulate the medicinal and/or recreational use of cannabis (Cannabis sativa L.). However, there is a lack of information on the impact of regular consumption of this subst...

Jan 6th, 2023 - Most states have enacted laws allowing individuals to treat chronic pain with cannabis.1 Evidence is mixed about whether medical cannabis serves as a substitute for prescription opioids or other pain treatments.2,3 Accurate estimates of cannabis u...

Jan 3rd, 2023 - Newswise — All patients undergoing procedures requiring anesthesia should be asked about cannabis use, according to guidelines released by the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine). The first U.S. guideline...

Mar 10th, 2023 - This project will characterize the microbiome and endocannabinoid system (ECS) in people with HIV (PWH) and how they relate to neuroinflammation and blood-brain barrier (BBB) function. The study hypothesizes that pathogenic alterations in the gut ...

Mar 9th, 2023 - Systemic sclerosis (SSc) is a connective tissue disease for which skin tightness is the hallmark. The disease is classified into 2 major subsets: limited cutaneous systemic sclerosis (lcSSc) and diffuse cutaneous systemic sclerosis (dcSSc) dependi...

Mar 9th, 2023 - It is believed that SCI-110 will be a valuable treatment option, especially for t those subjects with TS, who do not benefit from or do not tolerate first-line treatment with antipsychotics. Since there is evidence that currently available CBM imp...

Mar 7th, 2023 - Knee osteoarthritis (KOA) affects nearly 30% of adults aged 60 years or older and causes significant pain and disability.1 Neurophysiological testing (quantitative sensory testing (QST)) demonstrates that KOA pain has both peripheral and central m...

Mar 7th, 2023 - Screening and Eligibility Assessment. Individuals will be screened by the research study intake coordinator. An initial pre-screen focused on inclusion/exclusion psychiatric diagnoses, medical status, current medication regimen, and ability and wi...

Mar 8th, 2023 - March 8 (Reuters) - Trulieve Cannabis Corp reported a fall in its adjusted core profit for the fourth quarter on Wednesday, hurt by reduced inventory. The Florida-based company’s adjusted core profit fell to $85 million in the quarter ended Dec. 3...

Mar 3rd, 2023 - COPENHAGEN – Mortality rate, length of hospital stay, and cost of hospitalization all drop significantly in patients with inflammatory bowel disease (IBD) concurrently using cannabis, shows a study that supports wider availability of the substance.

Mar 1st, 2023 - The FDA approved a once-daily, extended-release version of deutetrabenazine (Austedo XR) in 6, 12, and 24 mg tablet strengths for adults with tardive dyskinesia and chorea associated with Huntington's disease, Teva Pharmaceuticals announced. The t...

Feb 14th, 2023 - Note that some links may require subscriptions. The World Health Organization said Equatorial Guinea confirmed its first-ever outbreak of Marburg virus disease, after one of eight samples tested positive. Nine deaths and 16 suspected cases have be...

Feb 8th, 2023 - Sleep complaints and cannabis use are common among University students and are related to detrimental effects on health. The aim of this study was to explore their association. This cross-sectional study based on the i-Share e-cohort included Fren...